Home | Business News | Browse by Publication | B | Biotech Week

New nephropathy study findings recently were published by researchers at Federal University.

Publication: Biotech Week
Publication Date: 16-SEP-09
Format: Online
Delivery: Immediate Online Access

Article Excerpt
"Aceltylcysteine has been evaluated in several small trials as a means of reducing the risk of contrast-induced nephropathy (CIN), however systematic reviews of these studies do not provide conclusive answers. Therefore, a large randomized controlled trial (RCT) is needed to provide a reliable answer as to whether acetylcysteine is effective in decreasing the risk of CIN...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Biotech Week
Researchers from University of Zurich provide details of new studies a..., September 16, 2009
Studies from Kitasato University, Medical Department yield new data on..., September 16, 2009
Research from J.I. Alvarez and co-authors reveals new findings on neur..., September 16, 2009
New neurodegenerative disease study results reported from North Caroli..., September 16, 2009
Nihon University, Medical Department reports research in neurofibromat..., September 16, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.